Dagousset F - Search Results

1

Radioiodine therapy of the autonomous thyroid nodule in patients with or without visible extranodular activity.

Clerc J, Dagousset F, Izembart M, Jais JP, Heshmati HM, Alcaïs A, Chevalier A, Léger AF, Barritault L. Clerc J, et al. Among authors: dagousset f. J Nucl Med. 1995 Feb;36(2):217-23. J Nucl Med. 1995. PMID: 7830117 Free article.

2

Influence of dose selection on absorbed dose profiles in radioiodine treatment of diffuse toxic goiters in patients receiving or not receiving carbimazole.

Clerc J, Izembart M, Dagousset F, Jaïs JP, Heshmati HM, Chevalier A, Léger AF, Barritault L. Clerc J, et al. Among authors: dagousset f. J Nucl Med. 1993 Mar;34(3):387-93. J Nucl Med. 1993. PMID: 8441028 Free article.

3

Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma.

Leger FA, Izembart M, Dagousset F, Barritault L, Baillet G, Chevalier A, Clerc J. Leger FA, et al. Among authors: dagousset f. Eur J Nucl Med. 1998 Mar;25(3):242-6. doi: 10.1007/s002590050223. Eur J Nucl Med. 1998. PMID: 9580856 Clinical Trial.

4

A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for sequential treatments.

Leger AF, Pellan M, Dagousset F, Chevalier A, Keller I, Clerc J. Leger AF, et al. Among authors: dagousset f. Br J Radiol. 2005 May;78(929):428-32. doi: 10.1259/bjr/92548685. Br J Radiol. 2005. PMID: 15845937 Review.

5

Temporary ovarian failure in thyroid cancer patients after thyroid remnant ablation with radioactive iodine.

Raymond JP, Izembart M, Marliac V, Dagousset F, Merceron RE, Vulpillat M, Vallée G. Raymond JP, et al. Among authors: dagousset f. J Clin Endocrinol Metab. 1989 Jul;69(1):186-90. doi: 10.1210/jcem-69-1-186. J Clin Endocrinol Metab. 1989. PMID: 2499590

6

Upper retropharyngeal node involvement in differentiated thyroid carcinoma demonstrated by 131I scintigraphy.

Leger AF, Baillet G, Dagousset F, Vincenot MI, Izembart M, Clerc J, Barritault L. Leger AF, et al. Among authors: dagousset f. Br J Radiol. 2000 Dec;73(876):1260-4. doi: 10.1259/bjr.73.876.11205668. Br J Radiol. 2000. PMID: 11205668

7

Outpatient thyroid remnant ablation using repeated low 131-iodine activities (740 MBq/20 mCix2) in patients with low-risk differentiated thyroid cancer.

Clerc J, Bienvenu-Perrard M, de Malleray CP, Dagousset F, Delbot T, Dreyfuss M, Groussin L, Marlowe RJ, Leger FA, Chevalier A. Clerc J, et al. Among authors: dagousset f. J Clin Endocrinol Metab. 2012 Mar;97(3):871-80. doi: 10.1210/jc.2011-1882. Epub 2012 Jan 11. J Clin Endocrinol Metab. 2012. PMID: 22238400

8

[Effect of radioactive iodine treatment on TSH receptor antibodies in Basedow's disease].

Heshmati HM, Dagousset F, Izembart M, Clerc J. Heshmati HM, et al. Among authors: dagousset f. Presse Med. 1992 Feb 15;21(6):268. Presse Med. 1992. PMID: 1532644 French. No abstract available.

9

Serum thyroglobulin levels in hypofunctioning nodules before and after surgery.

de Cremoux P, Izembart M, Dagousset F, Heshmati HM, Boutteville C, Vallée G. de Cremoux P, et al. Among authors: dagousset f. Klin Wochenschr. 1985 Oct 15;63(20):1052-4. doi: 10.1007/BF01739672. Klin Wochenschr. 1985. PMID: 4068609

10

[Serum thyroglobulin is elevated in patients with heterogeneous goiter during radioiodide scintigraphy, but normal in those with homogeneous goiter].

Izembart M, Heshmati HM, Dagousset F, de Cremoux P, Boutteville C, Vallée G. Izembart M, et al. Among authors: dagousset f. Schweiz Med Wochenschr. 1986 May 10;116(19):634-7. Schweiz Med Wochenschr. 1986. PMID: 3715440 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page